A carregar...
The Cost-effectiveness, Health Benefits, and Financial Costs of New Antiviral Treatments for Hepatitis C Virus
BACKGROUND: New hepatitis C virus (HCV) treatments deliver higher cure rates with fewer contraindications, increasing demand for treatment and healthcare costs. The cost-effectiveness of new treatments is unknown. METHODS: We conducted a microsimulation of guideline testing followed by alternative t...
Na minha lista:
| Publicado no: | Clin Infect Dis |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5759765/ https://ncbi.nlm.nih.gov/pubmed/25778747 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ220 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|